Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm

N C Med J. Nov-Dec 2013;74(6):494-8.

Abstract

Direct-to-consumer genomic testing is available to anyone willing to pay for it. We investigated the reliability and reproducibility of such testing by sending DNA samples to 2 popular companies and by reviewing current literature on this topic. The concerns that were initially raised about direct-to- consumer genomic testing still seem valid.

MeSH terms

  • Genetic Testing*
  • Humans
  • Patient Participation
  • Reproducibility of Results
  • Risk Assessment